Growth Hormone Peptides Explained: CJC, Ipamorelin, Sermorelin, MK-677 (Complete Guide)

If you've been looking into growth hormone peptides, you've probably come across CJC, ibuprofen, tessemorel, direct growth hormone, and maybe even IGF-1. They all touch the same system, but they enter it at completely different points, and that distinction is what separates people who get results from people who waste money stacking compounds that cancel each other out.

To understand why one compound works and another doesn't for your specific situation, you need to see the full system first, because without that picture the compounds themselves are just names, and the axis they all act on is what actually tells you which intervention belongs where.

Your growth hormone axis runs on three players, and most discussions only cover two of them. The first is GHRH, which stands for growth hormone releasing hormone. And this is produced in your hypothalamus, which is in your brain. It travels down to your pituitary gland and tells it to manufacture and release growth hormone. Think of GHRH as the production order, the signal that says "make more."

The second player is ghrelin, the hunger hormone produced in your gut. Ghrelin does two things simultaneously when it comes to growth hormone. It triggers the immediate release of stored growth hormone from your pituitary, and it suppresses the third player, which is the one most people never hear about.

That third player is somatostatin, and it functions as the brake on the entire system. When your IGF-1 levels rise high enough, your brain senses that and releases somatostatin to slow growth hormone production down. This is a safety mechanism because your body doesn't want unchecked growth hormone circulating indefinitely, so somatostatin pumps the brakes and brings everything back into balance.

And here's why that matters. When GHRH and ghrelin are firing together and somatostatin is suppressed, that's when you get your biggest growth hormone pulses. This happens naturally during deep sleep when you're fasted, because fasting creates the exact hormonal conditions the axis needs: low insulin, high ghrelin, and active GHRH signaling all at the same time. Both accelerators are down and the brake is off.

Now, once growth hormone gets released into your bloodstream, it travels to your liver. And your liver converts it into something called IGF-1, which stands for insulin-like growth factor one. And IGF-1 is what's actually doing most of the work. The fat mobilization, the muscle repair, the recovery, the collagen synthesis, the connective tissue remodeling. That's all IGF-1. So growth hormone is the signal, but IGF-1 is what's executing on that signal.

Your body handles the handoff between these two with elegant timing. You sleep fasted, you get the growth hormone pulse overnight, you wake up and eat, insulin rises, and your liver converts that circulating growth hormone into IGF-1. Growth hormone needs low insulin to do its fat mobilization work, and IGF-1 production needs insulin present to happen efficiently. The body sequences these two phases naturally through the sleep to feeding transition, so you get both effects without them interfering with each other.

There's one more piece of the system that changes how you think about every compound on the list, and that's pulsatility. Your body doesn't produce growth hormone as a steady drip. It produces it in sharp bursts followed by periods of quiet. And there's actually research that showed that pulsatile growth hormone effectively drives lipolysis, which is fat mobilization, while continuous elevation was virtually ineffective. The pattern of delivery matters as much as the total amount. A pulsatile pattern keeps growth hormone receptors sensitive and keeps the fat mobilization pathway active, while a flat continuous level causes those receptors to downregulate and the lipolytic signal to go silent. This distinction becomes the deciding factor when you start comparing compounds, because some preserve that pulse pattern and some destroy it.

So with that full picture in place, you can see how every compound you've heard of is just intervening at a different point along this same chain, and there are four levels of intervention, and understanding which level matches your goals is the entire decision.

The first level covers your GHRH analogs, which includes CJC1295, tessemorelin, and sermorelin, and these compounds mimic the GHRH signal from your hypothalamus, binding to receptors on your pituitary and telling it to produce more growth hormone. You're amplifying the production order, not bypassing it. CJC1295 without DAC is a standard in this category. It's stable, it clears quickly, which means you preserve that natural pulsatile release pattern we just talked about, and the side effect profile is very clean. Tessemorelin works through the exact same mechanism, the same pathway, the same receptor. The difference is that tessemorelin carries FDA approval and has CT scan data specifically measuring visceral fat reduction, but you're paying two to three times the cost for the same underlying biology. Sermorelin is the original, FDA approved for growth hormone deficiency in children, and it works, but it carries a broader side effect profile with potential cortisol and prolactin spikes compared to CJC.

The key concept with all level one compounds is that they're limited by your pituitary's maximum output, because they can only coax your pituitary to release what it's capable of producing and that capacity has a hard upper boundary. For most people's goals, that boundary is more than enough, but it's important to understand that it exists because that's the fundamental difference between this level and the next one.

Level two is your ghrelin agonists, and ipamorelin is the standard. It mimics the ghrelin signal, binding to the growth hormone secretagogue receptor on your pituitary, triggering immediate release of stored growth hormone while simultaneously suppressing somatostatin. It's doing both jobs natural ghrelin does, trigger and brake removal, in one molecule. And if you go back to the older options in this category like GHRP2, GHRP6, or hexarelin, those all caused massive cortisol spikes, prolactin issues, or intense hunger that made them impractical for most people. Ipamorelin gives you the growth hormone pulse without that baggage, which is why it became the go-to.

This is also why CJC plus ipamorelin became the standard stack. You're hitting both pathways simultaneously, GHRH on one side and ghrelin on the other, with the two cleanest compounds in each category. Research shows the synergistic effect produces significantly greater growth hormone release than either one alone. But even stacked together, you're still limited by that same pituitary ceiling. You've maximized the signal from both directions, but your pituitary can only respond with what it's naturally capable of producing.

And for some people, that's not enough.

Level three is direct HGH, and this is where the game changes because you're bypassing the signaling system entirely and growth hormone enters your bloodstream directly without waiting for your pituitary to produce it, which means the dose you inject is exactly what circulates and the output isn't capped by anything your body would naturally regulate. At the competitive level, the protocol is typically anabolic steroids for muscle protein synthesis, growth hormone for IGF-1 production, and fat mobilization. Dosing tiers run from one to two IUs for anti-aging, two to four for body composition, and four to eight or more for performance.

A common concern with HGH is that a single daily injection creates the kind of continuous elevation that kills the pulsatile pattern. But the half-life of HGH is about two to three hours, meaning it clears your system within ten to sixteen hours, and your pituitary can resume its own endogenous pulsing within twelve to eighteen hours after injection. Continuous elevation in the problematic sense means splitting your dose into multiple injections throughout the day, which is what actually flattens the natural rhythm and leads to receptor downregulation.

The other common fear is growth hormone gut, that distended midsection visible on some professional bodybuilders. That's actually from a high dose of growth hormone, typically 10-20 plus IUs a day, combined with high doses of insulin, 10-40 plus IUs daily, sustained over years. That's not something that happens at moderate doses with responsible use, and decades of competitive bodybuilding experience are consistent on that point.

One thing that changes how you think about HGH timing is the nighttime dosing approach some competitive athletes prefer. The reason is that it complements the natural slow wave sleep repair window, and growth hormone may actually deepen slow wave sleep, which is when your body does its most significant recovery work. So rather than just choosing morning injection for the lipolytic window, some athletes deliberately time their dose to amplify the recovery window instead, and the choice between those two timing strategies depends on whether fat loss or tissue repair is the higher priority.

Level four is direct IGF-1, which skips the entire pathway and goes straight to the end product. You're not signaling for growth hormone and you're not waiting for liver conversion. IGF-1 LR3 is the synthetic systemic version with a twenty to thirty hour half-life that distributes throughout the body. IGF-1 DES is the site-specific version with a twenty to thirty minute half-life and roughly ten times the potency, injected intramuscularly directly into the target tissue. Both require four to six week cycles because of receptor desensitization, and both carry the highest side effect profile on this list because there's no natural regulation, no feedback loop telling the system to slow down.

Now here's something most people get wrong, and it costs them real money. But research from Rosenthal and colleagues in 1986 published in the Journal of Clinical Investigation showed that when exogenous growth hormone is present, that the pituitary's response to GHRH signaling is suppressed by 86% to 94%. That means if you're injecting HGH while also running CJC and ipamorelin, your secretagogues are talking to a pituitary gland that's essentially not listening. You're paying for two levels and only getting the benefit of one. This is why you never stack across levels. You pick the level that matches your goals and you commit to it.

One of the best things about the growth hormone axis compared to the testosterone axis is how quickly it recovers. When you inject testosterone, your HPG axis shuts down within weeks and recovery takes approximately fifty-one weeks on average, which is why TRT is typically a lifetime commitment. The growth hormone axis recovers in forty-eight to sixty hours. The somatostatin receptors recycle and resensitize quickly rather than downregulating permanently. The somatotroph cells in your pituitary that produce growth hormone don't shrink or atrophy during suppression, they just go quiet and come back online when the exogenous signal stops. Your liver's conversion capacity stays completely intact throughout. And the suppression is functional, not structural, meaning the cells are all still there, fully intact, just paused, unlike testosterone where the Leydig cells in your testes physically atrophy.

So the decision framework comes down to matching your goals to the right level of intervention. For sleep, recovery, fat loss, connective tissue health, and general optimization, CJC plus ipamorelin is the answer for the vast majority of people. It's effective, affordable, works with your body's feedback system, and the axis recovers in days.

The muscle building benefits become meaningful when combined with androgens, because testosterone and IGF-1 both feed the same growth cascade inside your muscle cells. Growth hormone alone is relatively poor at building muscle in healthy adults, so if your testosterone isn't optimized and body composition is the primary goal, that's where you should start before adding growth hormone to the equation. Direct HGH makes sense when you need output beyond what your pituitary can produce, you already have your testosterone dialed in, and you're prepared for the additional monitoring and cost. And if you're an advanced athlete with medical oversight and specific tissue growth targets, IGF-1-LR3 for systemic effects, or IGF-1-DES for site-specific work.

Direct HGH and IGF-1 are tools for specific situations where you've already built the foundation, and your goals require output beyond what secretagogues can deliver.

The thing that makes this system different from almost every other hormonal axis in your body is that it wants to come back, because when you push it hard enough to suppress it, the underlying structure stays intact and the cells just wait rather than atrophy, so when the exogenous signal clears the whole axis picks back up where it left off and resumes on its own schedule. Which means the real question was never "which compound is strongest." It's which level of intervention lets you get what you need while keeping the system intact enough to keep working for you long after you stop.